THIOTEPA FOR INJECTION, BP
Google image searchProduct monograph
Active ingredient
thiotepa, 15 MG/VIAL
DIN: 02536862
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 27-JUN-2023
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01A — ALKYLATING AGENTS (ATC, ATC/DDD)
- L01AC — Ethylene imines (ATC, ATC/DDD)
- L01AC01 — THIOTEPA (ATC/DDD)
Pharmaceutical standard: BP
